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Sapna Sharma1, Justin M Ashley1, Alexandra Hodgson1 and Jeff Nisker1,2*Abstract
Objective: This study explores the views of pregnant women and clinicians regarding discussion of exposure to
phthalate plasticizers during pregnancy, subsequent to the 2011 Health Canada ban of certain phthalates at a
concentration greater than 1000 mg/kg in baby toys. This occurred with no regulation of products to which
pregnant women are exposed, such as food packaging and cosmetics.
Methods: Pregnant women, physicians and midwives were recruited through posters and pamphlets in prenatal
clinics in Southwestern Ontario for a semi-structured interview. All interviews were audiotaped, transcribed, and
subjected to rigorous qualitative analysis through a grounded theory approach, supported by NVIVO™ software.
Themes emerged from line by line, open, and axial coding in an iterative manner.
Results: Theoretical sufficiency was reached after 23 pregnant women and 11 clinicians had been interviewed. The
themes (and subthemes from which they arose) were: Theme I-Information Provision (IA-Sources of Information,
IB-Standardization, IC-Constraints, ID-Role of Government); Theme II-Risk (IIA-Significant Risk, IIB-Perceived Relevance,
IIC-Reconciliation); and Theme III- Factors Influencing Level of Concern (IIIA-Current Knowledge, IIIB-Demographic
Factors).
Conclusion: To respond to the increasing media and research attention regarding risk of phthalates to women,
and pregnant women in particular, national professional organizations should provide patient information. This
could include pamphlets on what a pregnant woman should know about phthalates and how they can be
avoided, as well as information to clinicians to facilitate this discussion.
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Phthalates (diesters of 1,2-benzenedicarboxylic phthalic
acid) are commonly present in food packaging, house-
hold cleaning products, and cosmetics [1,2]. In humans
phthalates cross the placenta, resulting in fetal exposure
that is closely correlated with maternal exposure [3], and
have been found in amniotic fluid [4] and breast milk [5,6].
Increased maternal phthalates exposure has been associ-
ated with increased luteinizing hormone and decreased
free testosterone [5], shortened anogenital distance [7],* Correspondence: jeff.nisker@lhsc.on.ca
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unless otherwise stated.reduced penile size and incomplete virilization [5,8,9],
altered semen quality [10,11], and preterm birth [12].
Exposure of pregnant women to phthalates has also
been associated with adverse childhood behavior and
executive functioning [13]. Braun, Sathyanarayana and
Hauser [14] in their review of “phthalate exposure and
children’s health” also draw attention to the correlation
of urinary phthalate metabolite concentrations in physical
growth [15,16] and allergic phenomena [17-20] in children.
In animal models, phthalates have been associated with
impaired spermatogenesis [21], cryptorchidism [22-24],
hypospadias [24,25] and reduced male fertility [22].
In 2006, the Center for the Evaluation of Reproductive
Risks to Humans completed an analysis of the develop-
mental and reproductive risks to humans of severall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Potential interview prompts to be used in
interviews of pregnant women and clinicians
1 Are you aware of any everyday environmental exposures that could
impact the health of your child during pregnancy?
2 Are you aware of the government warnings regarding Bisphenol A
and baby products like rubber duckies and baby bottles?
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to evaluate more precisely the risks associated with hu-
man exposure [26]. The European Union began regulat-
ing the concentrations of certain phthalates in children’s
toys in 1999, and eventually made their policies stricter
by implementing a ban in 2005 [27]. The United States
began regulating phthalates in children’s toys in 2008
[28]. Finally, in 2009, Canada placed phthalates on the
Hazardous Products Act, restricting the concentration of
certain phthalate esters to “no more than 1000 mg/kg in
the vinyl of all children’s toys and child care articles” [29].
Recently, Zimmer and coauthors (2012) [30] summa-
rizes the opinions of a group of experts in attendance at
the Health and Environment Network Conference in
Belgium in 2010. The goal was to support informed policy
making by facilitating the availability of relevant know-
ledge on phthalate exposure. Following expert opinion on
relevant issues, intrauterine exposure and reproductive
toxicity were prioritized as an area of further research.
This group also encouraged policy actions, including
monitoring, awareness raising, and restricting activities.
This implies that although additional research is needed
to further elucidate the risk that phthalates pose to human
health, the current scientific knowledge is sufficient for
using the precautionary principle to take policy actions
such as restrictions and banning. Finally, they encouraged
political action to protect groups at high risk of intrauter-
ine exposure [30].
Along with these regulations and bans came media
interest. As early as 2010, a CNN program on “5 toxins
that are everywhere,” advised viewers to “protect yourself”
from phthalates [31]. In 2011 an article in the popular
women’s magazine “Glamour” cautioned against “The
New Toxic Threats to Women’s Health”, and listed phtha-
lates as one of the five household chemicals to avoid [32].
Despite the Canadian ban on certain phthalates in
children’s toys, as well as media concern available to
pregnant women in Canada, no similar ban has been
proposed for products containing phthalates to which
pregnant women are exposed. As such, this study was
conducted to explore the views of pregnant women and
clinicians regarding information on phthalate exposure,
in order to elucidate any deficiencies in this process as
well as to develop possible solutions.3 Could you tell me what sources of information you tend to use in
regards to your children’s health?
4 What do you believe is the role/responsibility of your obstetrical care
provider when it comes to your health and the health of your child
during pregnancy?
5 Is there a point at which you think various parties should be
providing you or the general public with information regarding
potential risk? If so, who? And why? Please expand.
6 What do you believe is your role in obtaining information about
potential environmental risks to you and your child during
pregnancy?Methods
Recruitment
Pregnant women in Southwestern Ontario were invited
through posters and pamphlets in prenatal clinics, pre-
natal education classes, and prenatal fairs. Obstetricians,
family physicians, and midwives in Southwestern Ontario
were recruited through email, posters and pamphlets.
Research ethics approval was obtained through theWestern University’s Health Science Research Ethics
Board (17406E).
On the pamphlets was a paragraph, which provided
general information on phthalates:
“Phthalates are compounds that are used to make plas-
tics flexible in their final applications. They are used in
floor tiles, clothes, medical supplies, toys, food packaging,
and personal care products. These compounds have also
been shown to leach out of various products, and are also
present in appreciable amounts in our environment…..
mimic naturally occurring hormones in the body, interfer-
ing with the endocrine system to produce adverse devel-
opmental and reproductive effects. However, the full range
and extent of these effects have not yet been identified.”
Interviews
The 20–40 minute interviews were semi-structured,
conducted by SS, JA and AH, and the participants were
encouraged to provide their opinions at length. The non
leading potential interview prompts that could be of-
fered to the pregnant women were the same as those
that would be offered to the clinicians (Table 1). In our
research, participants were encouraged to speak freely
for as long as they wanted on phthalate exposure in
pregnancy and the prompts were only used if the partici-
pant’s opinions in the desired areas were not already
expressed. The interviews were audiotaped and tran-
scribed verbatim, including pauses and notes on the
emotional tone of the spoken text. All identifying informa-
tion was removed from the transcripts. The audiotapes
were erased following transcription of the interviews.
Analysis
The transcripts were entered into NVivo™ software
(QSR International Proprietary Limited Company Ltd,
Doncaster, Victoria, Australia), which allowed the re-
searchers to manage the large quantities of text for
THEMES SUBTHEMES CATEGORIES
Figure 1 Themes and the categories and subthemes from
which they arose.
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izing text and searching for words. The interview tran-
scripts underwent rigorous analysis using the analytical
techniques of grounded theory methodology [33,34],
which were specifically designed for analyzing complex
social processes [35]. The analysis was organized into
three phases: open, axial, and selective coding [33,34].
In open coding, the data were read and then fractured
by identifying chunks of data that relate to a theme or
idea. In axial coding, similar themes were organized into
conceptual categories. In selective coding, a core con-
cept was identified as the central theme of the study and
the conceptual categories organized in relation to the
core concept. Each stage of the coding process (open,
axial, and selective) provided a set of categories that
could be used to explore the emerging themes of the
views of pregnant women and clinicians regarding the
discussion of phthalate exposure in pregnancy. The axial
level of coding built on the open coding level, incorporat-
ing categories and creating new ones [33,34].
Theoretical sampling was maintained throughout the
analysis, and continued for as long as new themes and
relationships were discovered in the data [33,34]. By using
a process of constant comparison between the emerging
theory and codes with those that had come before, as re-
corded in ongoing research memos, a grounded theory ra-
ther than a description of themes was generated [33,34].
Results
Theoretical sufficiency [36] was reached after the tran-
scripts of 23 pregnant women and 11 clinicians (6 obstetri-
cians, 3 family physicians, 2 midwives) had been analyzed.
Comments of pregnant women and obstetrical care pro-
viders were grouped together to form 13 categories based
on content they shared (Figure 1). These categories were
then grouped together to form subthemes, which were
then combined to form the following themes: Theme I-
Information Provision, Theme II- Risk, and Theme III-
Factors Influencing Level of Concern (Figure 1).
Theme I - Information provision
From the subtheme of Sources of Information, preg-
nant women and clinicians commented on who should
be responsible for providing information on the risk of
phthalates exposure in pregnancy. For example, Pregnant
Woman 3 felt that: “The healthcare provider’s role is to…
keep…you healthy and unfortunately that’s the only per-
son that’s going to be able to do it”. Obstetrician 5 offered
a different position:
…I don’t think you should put the onus on the family
doc per se.… they’ve got so many things on their plate
they can’t be aware of any, sort of, potential exposure or
risk factor with pregnancy in the first trimester -OB5Pregnant Women 4 and 6 stressed the importance of
the pregnant woman finding information for herself:
…to an extent I believe you should be researching it
yourself because your obstetrician doesn’t have time to
know… everyday products that you are using, which
brand of product, and to be researching everything
herself…she should have a knowledge, but she doesn’t
have knowledge on every single product -PW4
Well, it’s, I mean, its parents’ responsibility to try,
you know, to look out for their children and do the
best they can to keep them healthy, particularly in
the womb when they’re most vulnerable. -PW6
Family Physician 1 highlighted the potential role of the
internet:
the vast majority [of patients] still come with the
confidence in their doctor to give them a kind of
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be-um inflamed or minimized. –FP1
Pregnant Woman 13 alluded to the overlap between
information provision from a physician, as well as from
the Internet:
…I’m usually…happy with what the doctor says but if
it was something that I’d read on the Internet then…
that’s something I would ask the doctor about it, but
if the doctor had said it in the first place I wouldn’t go
check on the Internet -PW13
Family Physician 2 commented:
…family physicians and midwives … have more access
to patients at an earlier stage of pregnancy. –FP2
Midwife 2 alluded to the possibility of incorporating
discussion of phthalates into post-partum care, as a
means of introducing this information prior to subsequent
pregnancies:
…we don’t see a lot of people, but actually we can do
it postpartum … when we’re doing our discharge visit
about when you can, when you want another baby,
folic acid and all that, um, so we can definitely put a
plug in there too. -MW2
The Theme of Information Provision also arose from the
subthemes of Standardization, Constraints, and the Role of
the Government. With respect to issues of Standardization,
Obstetrician 1 stated that:
…I think standardization could be done… combined
clinics where some of your prenatal clinics are as a
group first antenatal visits you could lump people in
8 weeks to 10 weeks, or make it a month span, …go
over all the prenatal stuff… -OB1
Alluding to perceived constraints on information pro-
vision, Obstetrician 2 and Midwife 1 felt that:
…only 50% of the pregnancies are planned, you do
need to target the fertile, um, population if you want
to do risk avoidance in pregnancy … the harmful
effects are greatest in the period the baby forms their
organs, um, you should really tackle them before
they’re six weeks pregnant and the first two weeks
before they miss a period are crucial. So they think
they’re pregnant and they can’t get an appointment
with their family doctor until two weeks later, so by
the time they see the family doctor organogenesis is
complete and, um, they are too late. –OB2and:
…we need a evidence-based pool of information that
we can actually say to women, here’s the evidence on
this… I think it’s always a difficult thing to, you know,
to make recommendations to women if you don’t
really have a solid background… –MW1
Finally, with respect to the role of the government in
information provision, Pregnant Woman 1 felt that:
Well, I think that there should be studies going on,
and government giving money to studies to make
sure we can reduce the risk of any problems down
the road …. –PW1
while Obstetrician 1 stated:
… the government should have some … sort of web
page that they can list these things on if people want
to know what’s in what and everything… -OB1
Theme II - Risk
Theme II was derived from the 3 subthemes: Significant
Risk, Perceived Relevance of Risk, and Reconciliation of
Risk. The subtheme of Significant Risk was contributed
to by Pregnant Woman 5, who stated:
Risk is risk, whether it’s great or small, right… and babies
are innocent so they deserve a fair shot, you know… I
know it might seem a small risk, but that one small risk
might be that risk that you didn’t have to take… -PW5
Regarding the subtheme of Perceived Relevance of
Risk, Obstetrician 1 found:
…it amusing the public fascination with this and
Bisphenol A and so forth, yet people smoke
throughout their pregnancies, yet people who drive
their SUVs with one person in the car with them, like,
like when you think about the volume of exposure
there are some things that are exposing us to much
more risk without question. –OB1
and Obstetrician 4 stated:
…I’m not going to pick on one particular item that
has the potential esoteric, ah. associated risk factor
that’s not proven through science, cause honestly that
can open up a kettle, ah can of worms… -OB4
Pregnant Woman 21 explained how she perceives
risk when it comes to the availability of products in the
Canadian market:
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think it’s safe to use. Like I shouldn’t have to take it
[laughs] everything I buy and say, is this safe or what.
I don’t and maybe I should question more but I don’t.
I just take it for granted… –PW21
Regarding the subtheme of Reconciliation of Risk,
Obstetrician 1 acknowledged that while there may exist
a risk of phthalate exposure in pregnancy, there may be
greater risks associated with exposure to alternate products:
….there may be a risk but then the benefits outweigh
the risks. I don’t know for the soft plastics, like, soft
plastics, but we can give our kids wooden toys but
they’re probably laced with lead or arsenic or
something. -OB1
Pregnant Woman 16 commented on how she recon-
ciles risk:
Ah, you know what, I find, you know, in this day and
age that just about everything could be of concern
anyway, and you know, the things, you know, we
don’t know, I guess, kinda of hard to avoid everything,
I guess, especially if it’s in your, you know, daily living,
you know, the exposures, so, kinda hard. -PW16
Whereas Pregnant Woman 1 reconciliation of risk
differs:
…we don’t buy plastic water bottles anymore, we
switched to the keep clean containers, the hard, hard
stainless steel”. –PW1
Theme III - Factors influencing level of concern
The third theme emerged from the subthemes of Current
Knowledge and Demographic Factors. The subtheme of
Current Knowledge was derived from comments such as
that of Obstetrician 2 who stated:
If I knew what products contain … phthalates…and
if I knew what to offer my patient and to how to
avoid those, then I probably would give more
information. –OB2
And Obstetrician 5 who commented:
…I think presently there isn’t that much data on
environmental risks and early fetal development so
I’m not sure that you can talk in detail about
environmental risks… -OB5
The second subtheme, Demographic Factors, was
derived from comments that formed the categories ofCountry of Origin, Socioeconomic Status, Geographic
Location, and Education, respectively. For example,
Obstetrician 2 commented that:
…I still don’t know what to tell my patient. So I can’t
say, you know, buy this kind of pillow but don’t buy
that, or buy this and don’t buy that and then the
second thing is that I think it’s very prevalent in the
affordable products and people often do not have the
financial resources to go any other way. -OB2
Pregnant Woman 6 shared:
…it concerns me being near the Chemical Valley, you
hear about the reserve out there, that there’s more
girls being born than boys, but we live in Camlachie,
which is part of the reason we moved a little further
away… -PW6
Family Physician 1 commented:
I would actually say that, um, educated women, I
mean with a higher level of education, probably have
more questions and concerns about… risks…Um, so
they are concerned but just in a broad sense I would
say, that ah, that sometimes a little bit of knowledge
then increases your anxiety about what potential you
could put your child at risk for. -FP1
Pregnant Woman 12 described how her professional
training has influenced how she is able to appraise risk:
[Being a nurse I’m] used to doing research papers and
term papers so you…know where to find the
information, whereas maybe your lay person might
not know where to go to find information, might just
plain Google and not realize some stuff that’s not as
relevant. -PW12
Discussion
The main research findings centered on the comments
of research participants in both groups, pregnant women
and clinicians, indicating their desire for more informa-
tion on the effect of phthalate plasticizer exposure on
the developing fetus, so that informed choice could be
made regarding whether there is a need to avoid phthalate
plasticizers in pregnancy, and, in the pregnant women
group, how to avoid them regardless of certainty of the
human and animal research. The comments of the clini-
cians indicated they were not willing to discuss phthalate
exposure with their patients until their professional orga-
nizations provided a clinical practice guideline precisely
outlining the risks of phthalate exposure in pregnancy,
while the pregnant women wanted information either
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possible regarding how to avoid phthalate plasticizers.
Pregnant women cared less about the certainty of the risks
of phthalate plasticizers then the clinicians, and were more
worried about the condemnation of phthalate plasticizers
in the media.
Given the animal [21-25] and human [3-11] research
suggesting adverse outcomes associated with prenatal
phthalate exposure, and the recent media attention en-
couraging women to avoid phthalates in household
products, the discussion of phthalate exposure in preg-
nancy can be important to pregnant women. However,
as indicated in Theme I - Information Provision, prenatal
care providers (obstetricians, family physicians, midwives)
in our research did not perceive engaging in the discussion
of phthalate exposure in pregnancy as relevant. The rea-
sons provided include: (i) limited resources (e.g., inter-
action time); (ii) limited scope of practice; and (iii) late
initial contact points. Sathyanarayana and coauthors
(2012) [37] suggest similar lack of education and interest
among clinicians caring for pregnant women and women
who are contemplating pregnancy regarding other envir-
onmental exposures and provide tools to assist clinicians
in counseling their patients. These discussions could
incorporate Theme III – Factors Influencing Level of
Concern found in our research as women could share
their perceptions, including those derived from media
portrayal of phthalates.
Considering Theme II - Risk, it is possible that clini-
cians find it difficult to discuss risks of phthalate expos-
ure because the research on humans is not definitive
and no firm clinical practice guidelines currently exist in
most countries. An American College of Obstetricians
and Gynecologists and American Society for Reproduct-
ive Medicine Committee Opinion on exposure to toxic
environmental agents does include endocrine disrupters
[38]. Furthermore, as prenatal care generally occurs fol-
lowing the period of organogenesis, the time during
which the embryo is most susceptible to the effects of
phthalate exposure [23], so it is important that women’s
health primary care clinicians who confine their practice
to the care of pregnant women or general obstetrics and
gynecology frequently would not be able to provide
counseling regarding phthalate exposure until it is poten-
tially too late. Thus, it is important that primary care phy-
sicians, whether or not they care for pregnant women, be
educated regarding and be able to discuss phthalate expos-
ure preconception and during pregnancy.
For pregnant women, the lack of a ban or even a cau-
tion label on household products containing phthalates
makes appreciation of risk complex. It is important
that education and discussion of phthalate exposure re-
lated to pregnancy occur, even though making a direct
causal relationship remains difficult due to incompleteunderstanding of the kinetics of phthalates, likely due
to the exposure of pregnant women to a mixture of
chemicals [39], for example, phthalates in cosmetics
usually coexist with parabens [5].
To raise awareness regarding the potential risks of
phthalate exposure to pregnant women, pamphlets and
online resources such as those prepared by the Depart-
ments of Obstetrics and Gynecology at the University of
California San Francisco and the University of Florida,
should be included in Canadian prenatal care and made
widely available to pregnant women. Given that family
physicians care for women preconceptually and early in
pregnancy, it is essential to have pamphlets available in
their offices. Further, information on potential phthalate
exposure should be included in continuing professional
development programs. For example, a continuing profes-
sional development tool entitled “Environmental Impacts
on Reproductive Health” has been developed by the Asso-
ciation of Reproductive Health Professionals (ARHP) and
Planned Parenthood Federation of America (PPFA) [40],
and an editorial entitled “Potential Toxicity of Synthetic
Chemicals: What You Should Know About Endocrine-
Disrupting Chemicals” appeared in the American Fam-
ily Physician as a resource for clinicians [41]. Perhaps
Canadian organizations with a vested interest in Re-
productive Health, including, the Society of Obstetri-
cians and Gynaecologists of Canada, Canadian College
of Family Physicians, and the Canadian Association of
Midwives, could consider producing similar materials
to enable clinicians to discuss with their patients the risks
and potential avoidance strategies phthalate exposure in
pregnancy.
Qualitative research is designed to delve deeper into
complex issues than is possible through surveying larger
numbers using quantitative approaches [35]. In rigorous
qualitative research we aim to present the comments of
the research participants in an open and balanced man-
ner, with the understanding that the findings may not be
generalizable beyond the research participants, and may
or may not be dependent to geographic location and so-
cioeconomic or other factors. Indeed qualitative re-
search findings should be considered as co-constructed
[42] between the research participants and the research
team. The results represent themes co-constructed from
the research participants comments but do not neces-
sarily capture all individual perceptions. Due to the
methodological limitations of constructivist grounded
theory, this research is not generalizable beyond the
pregnant women interviewed. Readers are encouraged
to consider the similarities and differences of their ex-
periences with those shared in this study. Further re-
search is needed to explore women’s experiences with
household chemical risks in other contexts, cultures,
and geographic locations.
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The increasing research and media attention regarding
the risks of phthalates in pregnancy may create concern
for pregnant women in Canada, thus prompting the need
to address such concerns in clinician-provided informa-
tion. The Society of Obstetricians and Gynaecologists of
Canada, the Canadian College of Family Physicians, and
the Canadian Association of Midwives should consider in-
cluding information on phthalate exposure in pregnancy
in their patient information strategies, and continuing
professional development opportunities.
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